Download Department of Radiation Oncology

Department of Radiation Oncology Publications
2012–June 30, 2013
1.
Abrams RA, Winter KA, Regine WF, Safran H, Hoffman JP, Lustig R, Konski AA, Benson AB,
Macdonald JS, Rich TA, Willett CG. Failure to adhere to protocol specified radiation therapy
guidelines was associated with decreased survival in RTOG 9704--a phase III trial of adjuvant
chemotherapy and chemoradiotherapy for patients with resected adenocarcinoma of the pancreas.
Int J Radiat Oncol Biol Phys. 2012 Feb 1;82(2):809–816. Epub 2011 Feb 1. PMID: 21277694;
PMCID: PMC313385.
2. Alexander BM, Wang M, Yung WK, Fine HA, Donahue BA, Tremont IW, Richards RS, Kerlin KJ,
Hartford AC, Curran WJ, Mehta MP. A phase II study of conventional radiation therapy and
thalidomide for supratentorial, newly-diagnosed glioblastoma (RTOG 9806). J Neurooncol. 2013
Jan;111(1):33–39. Epub 2012 Oct 20. PMID: 23086432
3. Authors on behalf of ICRP, Stewart FA, Akleyev AV, Hauer-Jensen M, Hendry JH, Kleiman NJ,
Macvittie TJ, Aleman BM, Edgar AB, Mabuchi K, Muirhead CR, Shore RE, Wallace WH. ICRP
publication 118: ICRP statement on tissue reactions and early and late effects of radiation in normal
tissues and organs--threshold doses for tissue reactions in a radiation protection context. Ann ICRP.
2012 Feb;41(1–2):1–322. PMID: 22925378
4. Awan M, Cohen R, Campassi C, Kesmodel S, Bellavance E, Tkaczuk K, Feigenberg S. Breast
MRI and its impact in partial breast irradiation. Appl Radiat Oncol. 2013;[Oct]:6–10.
5. Balcer-Kubiczek EK. Apoptosis in radiation therapy: a double-edged sword. Exp Oncol. 2012
Oct;34(3):277–285. PMID: 23070013
6. Barnholtz-Sloan JS, Yu C, Sloan AE, Vengoechea J, Wang M, Dignam JJ, Vogelbaum MA,
Sperduto PW, Mehta MP, Machtay M, Kattan MW. A nomogram for individualized estimation of
survival among patients with brain metastasis. Neuro Oncol. 2012 Jul;14(7):910–918. Epub 2012
Apr 27. PMID: 22544733; PMCID: PMC3379797
7. Batinic-Haberle I, Spasojevic I, Tse HM, Tovmasyan A, Rajic Z, St Clair DK, Vujaskovic Z,
Dewhirst MW, Piganelli JD. Design of Mnporphyrins for treating oxidative stress injuries and their
redox-based regulation of cellular transcriptional activities. Amino acids. 2012;42:95–113. Erratum
in: Amino Acids. 2012 Jan;42(1):115-6. PubMed PMID: 20473774; PubMed Central PMCID:
PMC3022969.
8. Beazley KE, Banyard D, Lima F, Deasey SC, Nurminsky DI, Konoplyannikov M, Nurminskaya
MV. Transglutaminase inhibitors attenuate vascular calcification in a preclinical model.
Arterioscler Thromb Vasc Biol. 2013 Jan;33(1):43–51. Epub 2012 Nov 1. PubMed PMID:
23117658; PubMed Central PMCID: PMC3544469
9. Beazley KE, Zhang T, Lima F, Pozharskaya T, Niger C, Tzitzikov E, Azimzadeh AM,
Nurminskaya M. Implication for transglutaminase 2-mediated activation of β-catenin signaling in
neointimal vascular smooth muscle cells in chronic cardiac allograft rejection. J Heart Lung
Transplant. 2012 Sep;31(9):1009–1017. Epub 2012 Jun 12. PubMed PMID: 22694852; PubMed
Central PMCID: PMC3509739
10. Beazley KE, Deasey S, Lima F, Nurminskaya MV. Transglutaminase 2-mediated activation of βcatenin signaling has a critical role in warfarin-induced vascular calcification. Arterioscler Thromb
Vasc Biol. 2012 Jan;32(1):123–130. PubMed PMID: 22034513; PubMed Central PMCID:
PMC3374407
11. Betof AS, Rabbani ZN, Hardee ME, Kim SJ, Broadwater G, Bentley RC, Snyder SA, Vujaskovic
Z, Oosterwijk E, Harris LN, Horton JK, Dewhirst MW, Blackwell KL. Carbonic anhydrase IX is a
predictive marker of doxorubicin resistance in early-stage breast cancer independent of HER2 and
TOP2A amplification. Br J Cancer. 2012 Feb 28;106(5):916–922. Epub 2012 Feb 14. PMID:
22333602; PMCID: PMC3305967
1
12. Betzel GT, Yi BY, Niu Y, Yu CX. Is RapidArc more susceptible to delivery uncertainties than
dynamic IMRT? Med Phys. 2012 Oct;39(10):5882–5890. PMID: 23039627; PMCID:
PMC3461049
13. Biermann JS, Adkins DR, Agulnik M, Benjamin RS, Brigman B, Butrynski JE, Cheong D, Chow
W, Curry WT, Frassica DA, Frassica FJ, Hande KR, Hornicek FJ, Jones RL, Mayerson J, McGarry
SV, McGrath B, Morris CD, O'Donnell RJ, Randall RL, Santana VM, Satcher RL, Siegel HJ, von
Mehren M, Bergman MA, Sundar H. Bone cancer. J Natl Compr Canc Netw. 2013 Jun
1;11(6):688–723. PMID: 23744868
14. Bissonnette J-P, Balter PA, Dong L, Langen KM, Lovelock DM, Miften M, Moseley DJ, Pouliot J,
Sonke J-J, Yoo S. Quality assurance for image-guided radiation therapy utilizing CT-based
technologies: A report of the AAPM TG-179. Med Phys. 2012;39(4):1946–1963. PubMed PMID:
22482616.
15. Booth C, MacVittie T; MCART Team. Christopher S. Potten, 1940–2012. Health Phys. 2012
Oct;103(4):339. PMID: 22929465
16. Booth C, Tudor G, Tonge N, Shea-Donohue T, MacVittie TJ. Evidence of delayed
gastrointestinal syndrome in high-dose irradiated mice. Health Phys. 2012 Oct;103(4):400–410.
PMID: 23091877; PMCID: PMC3551349
17. Booth C, Tudor G, Tudor J, Katz BP, MacVittie TJ. Acute gastrointestinal syndrome in high-dose
irradiated mice. Health Phys. 2012 Oct;103(4):383–399. PMID: 23091876; PMCID: PMC3530834
18. Cairncross G, Wang M, Shaw E, Jenkins R, Brachman D, Buckner J, Fink K, Souhami L,
Laperriere N, Curran W, Mehta M. Phase III trial of chemoradiotherapy for anaplastic
oligodendroglioma: long-term results of RTOG 9402. J Clin Oncol. 2013 Jan 20;31(3):337–343.
Epub 2012 Oct 15. PMID: 23071247
19. Chakravarti A, Wang M, Robins HI, Lautenschlaeger T, Curran WJ, Brachman DG, Schultz CJ,
Choucair A, Dolled-Filhart M, Christiansen J, Gustavson M, Molinaro A, Mischel P, Dicker AP,
Bredel M, Mehta M. RTOG 0211: a phase 1/2 study of radiation therapy with concurrent gefitinib
for newly diagnosed glioblastoma patients. Int J Radiat Oncol Biol Phys. 2013 Apr 1;85(5):1206–
1211. Epub 2012 Nov 22. PMID: 23182702
20. Chinnaiyan P, Won M, Wen PY, Rojiani AM, Wendland M, Dipetrillo TA, Corn BW, Mehta MP.
RTOG 0913: A phase 1 study of daily everolimus (RAD001) in combination with radiation therapy
and temozolomide in patients with newly diagnosed glioblastoma. Int J Radiat Oncol Biol Phys.
2013 May 29. [Epub ahead of print] PMID: 23725999
21. Choi M, Hayes JP, Mehta MP, Swisher A, Small WJ, Mittal BB, Macvicar GR, Kalapurakal JA,
Sejpal SV. Using intensity-modulated radiotherapy to spare the kidney in a patient with seminoma
and a solitary kidney: a case report. Tumori. 2013 Mar-Apr;99(2):38e–42e. PMID: 23748827
22. Chua HL, Plett PA, Sampson CH, Joshi M, Tabbey R, Katz BP, MacVittie TJ, Orschell CM.
Long-term hematopoietic stem cell damage in a murine model of the hematopoietic syndrome of
the acute radiation syndrome. Health Phys. 2012 Oct;103(4):356–366. PMID: 22929468
23. Chung H, Lim S, Court L, Balter P. Evaluation of dose variation to normal/critical structures for
lung hypofractionated stereotactic body radiation therapy. Practical Radiat Oncol. 2012;2(2):
24. DiCarlo AL, Jackson IL, Shah JR, Czarniecki CW, Maidment BW, Williams JP. Development and
licensure of medical countermeasures to treat lung damage resulting from a radiological or nuclear
incident. Radiat Res. 2012 May;177(5):717–721. Epub 2012 Apr 2. PMID: 22468704
25. Dipetrillo T, Suntharalingam M, Ng T, Fontaine J, Horiba N, Oldenburg N, Perez K, Birnbaum A,
Battafarano R, Burrows W, Safran H. Neoadjuvant paclitaxel poliglumex, cisplatin, and radiation
for esophageal cancer: a phase 2 trial. Am J Clin Oncol. 2012 Feb;35(1):64–67. PMID: 21297434
26. Dragan AI, Albrecht MT, Pavlovic R, Keane-Myers AM, Geddes CD. Ultra-fast pg/ml anthrax
toxin (protective antigen) detection assay based on microwave-accelerated metal-enhanced
fluorescence. Anal Biochem. 2012 Jun 1;425(1):54–61. Epub 2012 Mar 6. PMID: 22406431
2
27. Dragan AI, Pavlovic R, McGivney JB, Casas-Finet JR, Bishop ES, Strouse RJ, Schenerman MA,
Geddes CD. SYBR Green I: fluorescence properties and interaction with DNA. J Fluoresc. 2012
Jul;22(4):1189–1199. Epub 2012 Apr 26. PMID: 22534954
28. Farese AM, Cohen MV, Katz BP, Smith CP, Gibbs A, Cohen DM, MacVittie TJ. Filgrastim
improves survival in lethally irradiated nonhuman primates. Radiat Res. 2013 Jan;179(1):89–100.
Epub 2012 Dec 4. PMID: 23210705
29. Farese AM, Cohen MV, Katz BP, Smith CP, Jackson W 3rd, Cohen DM, MacVittie TJ. A
nonhuman primate model of the hematopoietic acute radiation syndrome plus medical management.
Health Phys. 2012 Oct;103(4):367–382. PMID: 22929469
30. Farese AM, Cohen MV, Stead RB, Jackson W 3rd, Macvittie TJ. Pegfilgrastim administered in an
abbreviated schedule, significantly improved neutrophil recovery after high-dose radiation-induced
myelosuppression in rhesus macaques. Radiat Res. 2012 Nov;178(5):403–413. Epub 2012 Sep 19.
PMID: 22991919
31. Feigenberg SJ, Campassi C, Sharma N, Yu JQ, Kesmodel SB, Patel R, Tkaczuk K. Integration
of modern imaging into the multidisciplinary setting: the radiation oncology perspective. Appl
Radiol.
2013;
available
at:
www.appliedradiology.com/Article.aspx?id=27246&terms=feigenberg.
32. Feliciano J, Feigenberg S, Mehta M. Chemoradiation for definitive, preoperative, or postoperative
therapy of locally advanced non-small cell lung cancer. Cancer J. 2013 May–Jun;19(3):222–230.
PMID: 23708069
33. Gaugler JE, Eppinger A, King J, Sandberg T, Regine WF. Coping and its effects on cancer
caregiving. Support Care Cancer. 2013 Feb;21(2):385–395. Epub 2012 Jun 21. PMID: 22717917
34. Ghobadi K, Ghaffari HR, Aleman DM, Jaffray DA, Ruschin M. Automated treatment planning for
a dedicated multi-source intracranial radiosurgery treatment unit using projected gradient and
grassfire algorithms. Med Phys. 2012 Jun;39(6):3134–141. PMID: 22755698
35. Gilbert MR, Kuhn J, Lamborn KR, Lieberman F, Wen PY, Mehta M, Cloughesy T, Lassman AB,
Deangelis LM, Chang S, Prados M. Cilengitide in patients with recurrent glioblastoma: the results
of NABTC 03-02, a phase II trial with measures of treatment delivery. J Neurooncol. 2012
Jan;106(1):147–153.. Epub 2011 Jul 8. PMID: 21739168
36. Gleason JF Jr, Kudrimoti M, Van Meter EM, Mohuiddin M, Regine WF, Valentino J, Kenady D,
Arnold SM. Low-dose fractionated radiation with induction chemotherapy for locally advanced
head and neck cancer: 5-year results of a prospective phase II trial. J Radiat Oncol. 2013;2(1):35–?.
37. Gojo I, Tan M, Fang HB, Sadowska M, Lapidus R, Baer MR, Carrier F, Beumer JH, Anyang BN,
Srivastava RK, Espinoza-Delgado I, Ross DD. Translational phase I trial of vorinostat
(suberoylanilide hydroxamic acid) combined with cytarabine and etoposide in patients with
relapsed, refractory, or high-risk acute myeloid leukemia. Clin Cancer Res. 2013 Apr
1;19(7):1838–1851. Epub 2013 Feb 12. PMID: 23403629
38. Gondi V, Hermann BP, Mehta MP, Tomé WA. Hippocampal dosimetry predicts neurocognitive
function impairment after fractionated stereotactic radiotherapy for benign or low-grade adult brain
tumors. Int J Radiat Oncol Biol Phys. 2012 Jul 15;83(4):e487–e493. Epub 2011 Dec 29. PMID:
22209148; PMCID: PMC3462659
39. Goodman KA, Regine WF, Dawson LA, Ben-Josef E, Haustermans K, Bosch WR, Turian J,
Abrams RA. Radiation Therapy Oncology Group consensus panel guidelines for the delineation of
the clinical target volume in the postoperative treatment of pancreatic head cancer. Int J Radiat
Oncol Biol Phys. 2012 Jul 1;83(3):901–908. Epub 2012 Apr 5. PMID: 22483737
40. Grace MB, Singh VK, Rhee JG, Jackson WE 3rd, Kao TC, Whitnall MH. 5-AED enhances
survival of irradiated mice in a G-CSF-dependent manner, stimulates innate immune cell function,
reduces radiation-induced DNA damage and induces genes that modulate cell cycle progression and
apoptosis. J Radiat Res. 2012 Nov 1;53(6):840-53. Epub 2012 Jul 22. PubMed PMID: 22843381;
PubMed Central PMCID: PMC3483857.
3
41. Guzzetta AA, Montgomery EA, Lyu H, Hooker CM, Meyer CF, Loeb DM, Frassica D, Weber KL,
Ahuja N. Epithelioid sarcoma: one institution's experience with a rare sarcoma. J Surg Res. 2012
Sep;177(1):116–122. Epub 2012 May 1. PMID: 22575361
42. Haisfield-Wolfe ME, McGuire DB, Soeken K, Geiger-Brown J, De Forge B, Suntharalingam M.
Prevalence and correlates of symptoms and uncertainty in illness among head and neck cancer
patients receiving definitive radiation with or without chemotherapy. Support Care Cancer. 2012
Aug;20(8):1885–1893. Epub 2011 Oct 4. PMID: 21964642
43. Harper J, Skerry C, Davis SL, Tasneen R, Weir M, Kramnik I, Bishai WR, Pomper MG,
Nuermberger EL, Jain SK. Mouse model of necrotic tuberculosis granulomas develops hypoxic
lesions. J Infect Dis. 2012;4:595–602. PMID:22198962. Article in PMC, no ID.
44. Hendry J, MacVittie T. Professor Christopher S. Potten (1940–2012). Int J Radiat Biol. 2013
Jan;89(1):65–66. Epub 2012 Oct 23. PMID: 23088723
45. Hoang T, Dahlberg SE, Schiller JH, Mehta MP, Fitzgerald TJ, Belinsky SA, Johnson DH.
Randomized phase III study of thoracic radiation in combination with paclitaxel and carboplatin
with or without thalidomide in patients with stage III non-small-cell lung cancer: the ECOG 3598
study. J Clin Oncol. 2012 Feb 20;30(6):616–622. Epub 2012 Jan 23. PMID: 22271472; PMCID:
PMC3295560
46. Howell DD, James JL, Hartsell WF, Suntharalingam M, Machtay M, Suh JH, Demas WF, Sandler
HM, Kachnic LA, Berk LB. Single-fraction radiotherapy versus multifraction radiotherapy for
palliation of painful vertebral bone metastases-equivalent efficacy, less toxicity, more convenient: a
subset analysis of Radiation Therapy Oncology Group trial 97-14. Cancer. 2013 Feb
15;119(4):888–896. Epub 2012 Nov 16. PMID: 23165743
47. Hu J, Sorensen E, Romar L, Hiivala NJ, Deers L, Gayden J, Watkins AC, Griffith BP, Wu ZJ.
Platelet glycoprotein Ib
 shedding: a nov
continuous-flow left ventricular assist device (CF-LVAD), J Heart Lung Transpl.
2012;31(4):S189–S190.
48. Hussain A, Wu Y, Mirmiran A, DiBiase S, Goloubeva O, Bridges B, Mannuel H, Engstrom C,
Dawson N, Amin P, Kwok Y. Long-term follow-up of a prospective trial of trimodality therapy of
weekly paclitaxel, radiation, and androgen deprivation in high-risk prostate cancer with or without
prior prostatectomy. Int J Radiat Oncol Biol Phys. 2012 Jan 1;82(1):167–174. Epub 2010 Oct 30.
PMID: 21036487
49. Indig FE, Rybanska I, Karmakar P, Devulapalli C, Fu H, Carrier F, Bohr VA. Nucleolin inhibits
G4 oligonucleotide unwinding by Werner helicase. PLoS One. 2012;7(6):e35229. Epub 2012 Jun 4.
PMID: 22675465; PMCID: PMC3366963
50. Jackson IL, Xu P, Hadley C, Katz BP, McGurk R, Down JD, Vujaskovic Z. A preclinical rodent
model of radiation-induced lung injury for medical countermeasure screening in accordance with
the FDA animal rule. Health Phys. 2012 Oct;103(4):463–473. PMID: 22929472; PMCID:
PMC3604892
51. Jackson IL, Zhang X, Hadley C, Rabbani Z, Zhang Y, Marks S, Vujaskovic Z. Temporal
expression of hypoxia associated genes in lungs following thoracic irradiation. Free Radic Biol
Med. 53(2):337–346. PMID: 22588005.
52. Jakacki RI, Burger PC, Zhou T, Holmes EJ, Kocak M, Onar A, Goldwein J, Mehta M, Packer RJ,
Tarbell N, Fitz C, Vezina G, Hilden J, Pollack IF. Outcome of children with metastatic
medulloblastoma treated with carboplatin during craniospinal radiotherapy: a Children's Oncology
Group Phase I/II study. J Clin Oncol. 2012 Jul 20;30(21):2648–2653. Epub 2012 Jun 4. PMID:
22665539
53. Keller LMM, Cohen R, Sopka DM, Li T, Li L, Anderson PA, Fowble BL, Freedman GM. Effect of
bra use during radiation therapy for large-breasted women: acute toxicity and treated heart and lung
volumes. Practical Radiat Oncol. 2013;3(1):9–15. PubMed PMID: 23459714; PubMed Central
PMCID: PMC3580873.
4
54. Kelsey CR, Jackson IL, Langdon S, Owzar K, Hubbs J, Vujaskovic Z, Das S, Marks LB. Analysis
of single nucleotide polymorphisms and radiation sensitivity of the lung assessed with an objective
radiologic endpoint. Clin Lung Cancer. 2013 May;14(3):267–274. Epub 2013 Jan 10. PMID:
23313170; PMCID: PMC3643296
55. Kelsey CR, Jackson L, Langdon S, Owzar K, Hubbs J, Vujaskovic Z, Das S, Marks LB. A
polymorphism within the promoter of the TGFβ1 gene is associated with radiation sensitivity using
an objective radiologic endpoint. Int J Radiat Oncol Biol Phys. 2012 Feb 1;82(2):e247–e255. Epub
2011 May 24. PMID: 21605940
56. Kim SY, Rhee JG, Song X, Prochownik EV, Spitz DR, Lee YJ. Breast cancer stem cell-like cells
are more sensitive to ionizing radiation than non-stem cells: role of ATM. PLoS One.
2012;7(11):e50423. Epub 2012 Nov 21. PubMed PMID: 23185620; PubMed Central PMCID:
PMC3503893.
57. Kimura M, Caso JR, Bañez LL, Koontz BF, Gerber L, Senocak C, Donatucci CF, Vujaskovic Z,
Moul JW, Polascik TJ. Predicting participation in and successful outcome of a penile rehabilitation
programme using a phosphodiesterase type 5 inhibitor with a vacuum erection device after radical
prostatectomy. BJU Int. 2012 Dec;110(11 Pt C):E931–E938. Epub 2012 Apr 23. PubMed PMID:
22520165.
58. Kimura M, Rabbani ZN, Zodda AR, Yan H, Jackson IL, Polascik TJ, Donatucci CF, Moul JW,
Vujaskovic Z, Koontz BF. Role of oxidative stress in a rat model of radiation-induced erectile
dysfunction. J Sex Med. 2012 Jun;9(6):1535–1549. Epub 2012 Apr 10. PMID: 22489731
59. Koltz MT, Polifka AJ, Saltos A, Slawson RG, Kwok Y, Aldrich EF, Simard JM. Long-term
outcome of Gamma Knife stereotactic radiosurgery for arteriovenous malformations graded by the
Spetzler-Martin classification. J Neurosurg. 2013 Jan;118(1):74–83. Epub 2012 Oct 19. PMID:
23082882
60. Koontz BF, Quaranta BP, Pura JA, Lee WR, Vujaskovic Z, Gerber L, Haake M, Anscher MS,
Robertson CN, Polascik TJ, Moul JW. Phase 1 Trial of neoadjuvant radiation therapy before
prostatectomy for high-risk prostate cancer. Int J Radiat Oncol Biol Phys. 2013 Jun 19. [Epub
ahead of print] PMID: 23790772
61. Krupp DR, Xu PT, Thomas S, Dellinger A, Etchevers HC, Vekemans M, Gilbert JR, Ashley-Koch
AE, Gregory SG. Transcriptome profiling of genes involved in neural tube closure during human
embryonic development using long serial analysis of gene expression (Long-SAGE). Birth Defects
Res A Clin Mol Teratol. 2012;94(9):683–692. PubMed PMID: 22806986; PubMed Central PMCID:
PMC3438356.
62. Kruser TJ, McCabe BP, Mehta MP, Khuntia D, Campbell TC, Geye HM, Cannon GM.
Reirradiation for locoregionally recurrent lung cancer: outcomes in small cell and non-small cell
lung carcinoma. Am J Clin Oncol. 2013 Jan 24. [Epub ahead of print] PubMed PMID: 23357968.
63. Kruser TJ, Mehta MP, Robins HI. Pseudoprogression after glioma therapy: a comprehensive
review. Expert Rev Neurother. 2013 Apr;13(4):389-403. PubMed PMID: 23545054.
64. Kwok YM, Irani FG, Tay KH, Yang CC, Padre CG, Tan BS. Effective dose estimates for cone
beam computed tomography in interventional radiology. Eur Radiol. 2013 Jun 21. [Epub ahead of
print] PMID: 23793520
65. Lall RR, Shafizadeh SF, Lee KH, Mao Q, Mehta M, Raizer J, Bendok BR, Chandler JP. Orbital
metastasis of pituitary growth hormone secreting carcinoma causing lateral gaze palsy. Surg Neurol
Int. 2013 Apr 18;4:59. PubMed PMID: 23646269; PubMed Central PMCID: PMC3640222
66. Langen KM, Chauhan B, Siebers JV, Moore JA, Kupelian P. The dosimetric effect of intrafraction
prostate motion on step-and-shoot IMRT plans––magnitude, correlation with motion parameters,
and comparison with helical tomotherapy plans. Int J Radiat Oncol Biol Phys. 2012;84(5):1220–
1225. PubMed PMID: 22483699; PubMed Central PMCID: PMC3393775
67. Lee EQ, Kuhn J, Lamborn KR, Abrey L, DeAngelis LM, Lieberman F, Robins HI, Chang SM,
Yung WK, Drappatz J, Mehta MP, Levin VA, Aldape K, Dancey JE, Wright JJ, Prados MD,
Cloughesy TF, Gilbert MR, Wen PY. Phase I/II study of sorafenib in combination with
5
68.
69.
70.
71.
72.
73.
74.
75.
76.
77.
78.
79.
80.
temsirolimus for recurrent glioblastoma or gliosarcoma: North American Brain Tumor Consortium
study 05-02. Neuro Oncol. 2012 Dec;14(12):1511–1518. Epub 2012 Oct 24. PMID: 23099651;
PMCID: PMC3499017
Li S, DeWeese T, Movsas B, Liu D, Frassica D, Kim J, Chen Q, Walker E. Initial validation and
clinical experience with 3D optical-surface-guided whole breast irradiation of breast cancer.
Technol Cancer Res Treat. 2012 Feb;11(1):57–68. PMID: 22181332
Li L, Li T, Cohen R, Anderson P, Goldstein L, Bleicher R, Freedman G. (2012) Identifying
patients who may be candidates for a clinical trial of salvage accelerated partial breast irradiation
after previous whole breast irradiation. Int J Breast Cancer. Article ID: 937658. Available at:
www.hindawi.com/journals/ijbc/2012/937658/
Lim S, Ma SY, Jeung TS, Yi BY, Lee SH, Lee S, Cho SJ, Choi J. Development of a one-stop beam
verification system using electronic portal imaging devices for routine quality assurance. Med
Dosim. 2012 Autumn;37(3):296-304. Epub 2012 Jan 25. PubMed PMID: 22277157.
Lin SH, George TJ, Ben-Josef E, Bradley J, Choe KS, Edelman MJ, Guha C, Krishnan S, Lawrence
TS, Le QT, Lu B, Mehta M, Peereboom D, Sarkaria J, Seong J, Wang D, Welliver MX, Coleman
CN, Vikram B, Yoo S, Chung CH; Participants on Workshop for Preclinical and Clinical
Development of Radiosensitizers; National Cancer Institute. Opportunities and challenges in the era
of molecularly targeted agents and radiation therapy. J Natl Cancer Inst. 2013 May
15;105(10):686-93. Epub 2013 Mar 15. PMID: 23503600
Lu W, Tan S, Kim G, Feigenberg S, Zhang H, Kligerman S, Chen W, D’Souza WD,
Suntharalingam. M. Pre-chemoradiation therapy FDG PET/CT cannot identify residual
metabolically active areas in patients with locally advanced esophageal cancer. Int J Radiat Oncol
Biol Phys. 2012;84(3 suppl):S312.
Lubbe W, Cohen R, Sharma N, Ruth K, Peters R, Li J, Buyyounouski M, Kutikov A, Chen D,
Uzzo R, Horwitz E. Biochemical and clinical experience with real-time intraoperatively planned
permanent prostate brachytherapy. Brachytherapy. 2012;11(3):209–213. PubMed PMID:
21727033.
MacVittie TJ, Bennett A, Booth C, Garofalo M, Tudor G, Ward A, Shea-Donohue T, Gelfond
D, McFarland E, Jackson W 3rd, Lu W, Farese AM. The prolonged gastrointestinal syndrome in
rhesus macaques: the relationship between gastrointestinal, hematopoietic, and delayed multi-organ
sequelae following acute, potentially lethal, partial-body irradiation. Health Phys. 2012
Oct;103(4):427–453. PMID: 22929471
MacVittie TJ, Farese AM, Bennett A, Gelfond D, Shea-Donohue T, Tudor G, Booth C,
McFarland E, Jackson W 3rd. The acute gastrointestinal subsyndrome of the acute radiation
syndrome: a rhesus macaque model. Health Phys. 2012 Oct;103(4):411–426. PMID: 22929470
MacVittie TJ. The MCART Consortium animal models series. Health Phys. 2012 Oct;103(4):340–
342. PMID: 22929466
Mahmood U, Errens M, Zimrin A, Hanna N, Amin P, Sharma N. The remarkably distensible
stomach: case report highlighting the implications of gastric filling on radiation treatment planning
for gastric lymphoma. Practical Radat Oncol. 2012;2(4):265–269.
Mahmood U, Hanlon AL, Koshy M, Buras R, Chumsri S, Tkaczuk KH, Cheston SB, Regine WF,
Feigenberg SJ. Increasing national mastectomy rates for the treatment of early stage breast cancer.
Ann Surg Oncol. 2013 May;20(5):1436–1443. Epub 2012 Nov 8. PMID: 23135312
Mahmood U, Morris C, Neuner G, Koshy M, Kesmodel S, Buras R, Chumsri S, Bao T, Tkaczuk K,
Feigenberg S. Similar survival with breast conservation therapy or mastectomy in the management
of young women with early-stage breast cancer. Int J Radiat Oncol Biol Phys. 2012 Aug
1;83(5):1387–1393. Epub 2012 Jan 31. PMID: 22300561
Malinowski KT, McAvoy TJ, George R, Dieterich S, D’Souza WD. Incidence of changes in
respiration-induced tumor motion and its relationship with respiratory surrogates during individual
treatment fractions. Int J Radiat Oncol Biol Phys. 2012;82:1665–1773. PubMed PMID: 22429333;
PubMed Central PMCID: PMC3346954.
6
81. Malinowski K, McAvoy TJ, George R, Dieterich S, D'Souza WD. Online monitoring and error
detection of real-time tumor displacement prediction accuracy using control limits on respiratory
surrogate statistics. Med Phys. 2012 Apr;39(4):2042–2048. PMID: 22482625; PubMed Central
PMCID: PMC3321053
82. Malinowski KT, McAvoy TJ, George R, Dieterich S, D'Souza WD. Mitigating errors in external
respiratory surrogate-based models of tumor position. Int J Radiat Oncol Biol Phys. 2012 Apr
1;82(5):e709–e716. PMID: 22429333; PMCID: PMC3346954
83. McGurk R, Hadley C, Jackson IL, Vujaskovic Z. Development and dosimetry of a small animal
lung irradiation platform. Health Phys. 2012 Oct;103(4):454–462. PMID: 23091878
84. Miriyala S, Spasojevic I, Tovmasyan A, Salvemini D, Vujaskovic Z, St Clair D, Batinic-Haberle I.
Manganese superoxide dismutase, MnSOD and its mimics. Biochim Biophys Acta. 2012
May;1822(5):794–814. Epub 2011 Dec 9. Review. PMID: 22198225; PMCID: PMC3304004
85. Mistry N, Pokharel S, Diwanji T, Feigenberg S, D’Souza WD. SU-C-217BCD-01: Breathing
maneuvers result in regional changes in ventilation as assessed by 4D-CT. Med Phys.
2012;39(6):3605.
86. Mutaf YD, Zhang J, Yu CX, Yi BY, Prado K, D'Souza WD, Regine WF, Feigenberg SJ.
Dosimetric and geometric evaluation of a novel stereotactic radiotherapy device for breast cancer:
the GammaPod™. Med Phys. 2013 Apr;40(4):041722. PMID: 23556892
87. Muvarak N, Nagaria P, Rassool FV. Genomic instability in chronic myeloid leukemia: targets for
therapy? Curr Hematol Malig Rep. 2012 Jun;7(2):94–102. PMID: 22427031
88. Nagaria P, Robert C, Rassool FV. DNA double-strand break response in stem cells: mechanisms
to maintain genomic integrity. Biochim Biophys Acta. 2013 Feb;1830(2):2345–2353. Epub 2012
Sep 17. PMID: 22995214
89. Nagaria P, Svilar D, Brown AR, Wang XH, Sobol RW, Wyatt MD. SMUG1 but not UNG DNA
glycosylase contributes to the cellular response to recovery from 5-fluorouracil induced replication
stress. Mutat Res. 2013 Mar-Apr;743-744:26–32. Epub 2012 Dec 17. PMID: 23253900; PMCID:
PMC3616158
90. Neuner G, Mohiuddin MM, Vander Walde N, Goloubeva O, Ha J, Yu CX, Regine WF. High-dose
spatially fractionated GRID radiation therapy (SFGRT): a comparison of treatment outcomes with
Cerrobend vs. MLC SFGRT. Int J Radiat Oncol Biol Phys. 2012 Apr 1;82(5):1642–1649. Epub
2011 Apr 29. PMID: 21531514
91. Neuner GA, Badros AA, Meyer TK, Nanaji NM, Regine WF. Complete resolution of laryngeal
amyloidosis with radiation treatment. Head Neck. 2012 May;34(5):748–752. Epub 2010 Nov 10.
PMID: 22488785
92. Nichols EM, Feigenberg SJ, Marter K, Cheston SB, Lasio G, Tkaczuk K, Kesmodel S, Buras R,
Regine WF. Preoperative radiation therapy significantly increases patient eligibility for accelerated
partial breast irradiation using 3D-conformal radiotherapy. Am J Clin Oncol. 2013 Jun;36(3):232–
238. PMID: 22549267
93. Nichols RC Jr, Huh SN, Prado KL, Yi BY, Sharma NK, Ho MW, Hoppe BS, Mendenhall NP, Li
Z, Regine WF. Protons offer reduced normal-tissue exposure for patients receiving postoperative
radiotherapy for resected pancreatic head cancer. Int J Radiat Oncol Biol Phys. 2012 May
1;83(1):158–163. Epub 2012 Jan 13. PMID: 22245197
94. Nieder C, Grosu AL, Mehta MP. Brain metastases research 1990-2010: pattern of citation and
systematic review of highly cited articles. Sci World J. 2012;2012:721598. Epub 2012 Sep 17.
Review. PMID: 23028253; PMCID: PMC3458272
95. Niu Y, Zhang G, Berman BL, Parke WC, Yi B, Yu CX. Improving IMRT-plan quality with MLC
leaf position refinement post plan optimization. Med Phys. 2012 Aug;39(8):5118-26. PubMed
PMID: 22894437; PubMed Central PMCID: PMC3416882.
96. Odén J, Toma-Dasu I, Yu CX, Feigenberg SJ, Regine WF, Mutaf YD. Dosimetric comparison
between intra-cavitary breast brachytherapy techniques for accelerated partial breast irradiation and
7
a novel stereotactic radiotherapy device for breast cancer: GammaPod™. Phys Med Biol. 2013 Jul
7;58(13):4409–4421. Epub 2013 Jun 6. PMID: 23743718
97. Ogiwara H, Kalakota K, Rakhra SS, Helenowski IB, Marymont MH, Kalapurakal JA, Mehta MP,
Levy RB, Chandler JP. Intracranial relapse rates and patterns, and survival trends following postresection cavity radiosurgery for patients with single intracranial metastases. J Neurooncol. 2012
May;108(1):141–146. Epub 2012 Mar 18. PMID: 22426925
98. Pamboukian R, Carrier F. hnRNP A18: A new pathway to regulate protein translation in cancer
cells. Mol Cell Pharmacol. 2012;4(1):41–48.
99. Patel S, DiBiase S, Meisenberg B, Flannery T, Patel A, Dhople A, Cheston S, Amin P. Phase I
clinical trial assessing temozolomide and tamoxifen with concomitant radiotherapy for treatment of
high-grade glioma. Int J Radiat Oncol Biol Phys. 2012 Feb 1;82(2):739–742. Epub 2011 Feb 25.
PMID: 21353747
100. Patel S, Macdonald OK, Nagda S, Bittner N, Suntharalingam M. Evaluation of the role of
radiation therapy in the management of malignant thymoma. Int J Radiat Oncol Biol Phys. 2012
Apr 1;82(5):1797–1801. Epub 2011 May 17. PMID: 21596484
101. Plett PA, Sampson CH, Chua HL, Joshi M, Booth C, Gough A, Johnson CS, Katz BP, Farese AM,
Parker J, MacVittie TJ, Orschell CM. Establishing a murine model of the hematopoietic syndrome
of the acute radiation syndrome. Health Phys. 2012 Oct;103(4):343–355. PMID: 22929467
102. Preusser M, Capper D, Ilhan-Mutlu A, Berghoff AS, Birner P, Bartsch R, Marosi C, Zielinski C,
Mehta MP, Winkler F, Wick W, von Deimling A. Brain metastases: pathobiology and emerging
targeted therapies. Acta Neuropathol. 2012 Feb;123(2):205–222. Epub 2012 Jan 3. PMID:
22212630
103. Raparia K, Villa C, DeCamp MM, Patel JD, Mehta MP. Molecular profiling in non-small cell lung
cancer: a step toward personalized medicine. Arch Pathol Lab Med. 2013 Apr;137(4):481–491.
PMID: 23544937
104. Richardson S, Garcia-Ramirez J, Lu W, Myerson RJ, Parikh P. Design and dosimetric
characteristics of a new endocavitary contact radiotherapy system using an electronic brachytherapy
source. Med Phys. 2012;39:6838–6846. PubMed PMID: 23127076.
105. Robert C, Rassool FV. HDAC inhibitors: roles of DNA damage and repair. Adv Cancer Res.
2012;116:87–129. PMID: 23088869.
106. Royak-Schaler R, Pelser C, Langenberg P, Hayes J, Gardner L, Nesbitt K, Citron W, Drogula CL,
Dwyer D. Characteristics associated with the initiation of radiation therapy after breast-conserving
surgery among African American and white women diagnosed with early-stage breast cancer in
Maryland, 2000-2006. Ann Epidemiol. 2012 Jan;22(1):28–36. Epub 2011 Oct 28. PMID: 22037379
107. Rubinstein TJ, Mehta MP, Schoenfield L, Perry JD. Orbital xanthogranuloma in an adult patient
with xanthelasma palpebrarum and hypercholesterolemia. Ophthal Plast Reconstr Surg. 2013 Mar
14. [Epub ahead of print] PMID: 23503059
108. Seung SK, Larson DA, Galvin JM, Mehta MP, Potters L, Schultz CJ, Yajnik SV, Hartford AC,
Rosenthal SA. American College of Radiology (ACR) and American Society for Radiation
Oncology (ASTRO) Practice Guideline for the Performance of Stereotactic Radiosurgery (SRS).
Am J Clin Oncol. 2013 Jun;36(3):310–315. PMID: 23681017
109. Shaw EG, Wang M, Coons SW, Brachman DG, Buckner JC, Stelzer KJ, Barger GR, Brown PD,
Gilbert MR, Mehta MP. Randomized trial of radiation therapy plus procarbazine, lomustine, and
vincristine chemotherapy for supratentorial adult low-grade glioma: initial results of RTOG 9802. J
Clin Oncol. 2012 Sep 1;30(25):3065–3070. Epub 2012 Jul 30. PMID: 22851558
110. Skerry CM, Harper J, Weir M, Bishai WR, Jain SK. Adjunctive TNF inhibition with standard
treatment enhances bacterial clearance in a murine model of necrotic TB granulomas. PloS One.
2012;7(6):e39680. PubMed PMID: 22198962; PubMed Central PMCID: PMC3266133.
111. Smeenk RJ, Louwe RJW, Langen KM, Shah AP, Kupelian PA, van Lin ENJTh, Kaanders JHAM.
An endorectal balloon reduces intrafraction prostate motion during radiotherapy. Int J Radiat Oncol
Biol Phys. 2012;83(2):661–669. PubMed PMID: 22099035
8
112. Sperduto PW, Kased N, Roberge D, Xu Z, Shanley R, Luo X, Sneed PK, Chao ST, Weil RJ, Suh J,
Bhatt A, Jensen AW, Brown PD, Shih HA, Kirkpatrick J, Gaspar LE, Fiveash JB, Chiang V,
Knisely JP, Sperduto CM, Lin N, Mehta M. Summary report on the graded prognostic assessment:
an accurate and facile diagnosis-specific tool to estimate survival for patients with brain metastases.
J Clin Oncol. 2012 Feb 1;30(4):419–425. Epub 2011 Dec 27. PMID: 22203767; PMCID:
PMC3269967
113. Sperduto PW, Kased N, Roberge D, Chao ST, Shanley R, Luo X, Sneed PK, Suh J, Weil RJ, Jensen
AW, Brown PD, Shih HA, Kirkpatrick J, Gaspar LE, Fiveash JB, Chiang V, Knisely JP, Sperduto
CM, Lin N, Mehta M. The effect of tumor subtype on the time from primary diagnosis to
development of brain metastases and survival in patients with breast cancer. J Neurooncol. 2013
May;112(3):467-72. Epub 2013 Mar 6. PubMed PMID: 23462853
114. Sperduto PW, Wang M, Robins HI, Schell MC, Werner-Wasik M, Komaki R, Souhami L,
Buyyounouski MK, Khuntia D, Demas W, Shah SA, Nedzi LA, Perry G, Suh JH, Mehta MP. A
phase 3 trial of whole brain radiation therapy and stereotactic radiosurgery alone versus WBRT and
SRS with temozolomide or erlotinib for non-small cell lung cancer and 1 to 3 brain metastases:
Radiation Therapy Oncology Group 0320. Int J Radiat Oncol Biol Phys. 2013 Apr 1;85(5):1312–
1318. Epub 2013 Feb 4. PMID: 23391814
115. Stewart SB, Bañez LL, Robertson CN, Freedland SJ, Polascik TJ, Xie D, Koontz BF, Vujaskovic
Z, Lee WR, Armstrong AJ, Febbo PG, George DJ, Moul JW. Utilization trends at a
multidisciplinary prostate cancer clinic: initial 5-year experience from the Duke Prostate Center. J
Urol. 2012 Jan;187(1):103–108. Epub 2011 Nov 16. PMID: 22088334
116. Strongin A, Yovino S, Taylor R, Wolf J, Cullen K, Zimrin A, Strome S, Regine W,
Suntharalingam M. Primary tumor volume is an important predictor of clinical outcomes among
patients with locally advanced squamous cell cancer of the head and neck treated with definitive
chemoradiotherapy. Int J Radiat Oncol Biol Phys. 2012 Apr 1;82(5):1823–1830. Epub 2011 May 5.
PMID: 21549516
117. Suntharalingam M, Kwok Y, Goloubeva O, Parekh A, Taylor R, Wolf J, Zimrin A, Strome S, Ord
R, Cullen KJ. Phase II study evaluating the addition of cetuximab to the concurrent delivery of
weekly carboplatin, paclitaxel, and daily radiotherapy for patients with locally advanced squamous
cell carcinomas of the head and neck. Int J Radiat Oncol Biol Phys. 2012 Apr 1;82(5):1845–1850.
Epub 2011 May 19. PMID: 21601372
118. Suntharalingam M, Paulus R, Edelman MJ, Krasna M, Burrows W, Gore E, Wilson LD, Choy H.
Radiation therapy oncology group protocol 02-29: a phase II trial of neoadjuvant therapy with
concurrent chemotherapy and full-dose radiation therapy followed by surgical resection and
consolidative therapy for locally advanced non-small cell carcinoma of the lung. Int J Radiat Oncol
Biol Phys. 2012 Oct 1;84(2):456–463. Epub 2012 Apr 28. PMID: 22543206
119. Swift JM, Lima F, Macias BR, Allen MR, Greene ES, Shirazi-Fard Y, Kupke JS, Hogan HA,
Bloomfield SA. Partial weightbearing does not prevent musculoskeletal losses associated with
disuse. Med Sci Sports Exerc. 2013 May 7. [Epub ahead of print] PubMed PMID: 23657172.
120. Tan S, Kligerman S, Chen W, Lu M, Kim G, Feigenberg S, D'Souza WD, Suntharalingam M,
Lu W. Spatial-temporal [¹8F]FDG-PET features for predicting pathologic response of esophageal
cancer to neoadjuvant chemoradiation therapy. Int J Radiat Oncol Biol Phys. 2013 Apr
1;85(5):1375–1382. Epub 2012 Dec 6. PMID: 23219566; PMCID: PMC3606641
121. Thomas SN, Waters KM, Morgan WF, Yang AJ, Baulch JE. Quantitative proteomic analysis of
mitochondrial proteins reveals prosurvival mechanisms in the perpetuation of radiation-induced
genomic instability. Free Radic Biol Med. 2012 Aug 1;53(3):618–628. Epub 2012 Apr 19. PMID:
22569412
122. Tobin LA, Robert C, Nagaria P, Chumsri S, Twaddell W, Ioffe OB, Greco GE, Brodie AH,
Tomkinson AE, Rassool FV. Targeting abnormal DNA repair in therapy-resistant breast cancers.
Mol Cancer Res. 2012 Jan;10(1):96–107. Epub 2011 Nov 23. PMID: 22112941; PMCID:
PMC3319138
9
123. Tobin LA, Robert C, Rapoport AP, Gojo I, Baer MR, Tomkinson AE, Rassool FV. Targeting
abnormal DNA double-strand break repair in tyrosine kinase inhibitor-resistant chronic myeloid
leukemias. Oncogene. 2013 Apr 4;32(14):1784–1793. Epub 2012 May 28. PMID: 22641215
124. Tome WA, Gondi V, Mehta MP. In regards to Kirby et al. "Physics strategies for sparing neural
stem cells during whole-brain radiation treatments," [Med. Phys. 38, 5338 (2011)]. Med Phys. 2012
Mar;39(3):1677–1678; author reply 1679. PMID: 22380400
125. Tovmasyan A, Sheng H, Weitner T, Arulpragasam A, Lu M, Warner DS, Vujaskovic Z,
Spasojevic I, Batinic-Haberle I. Design, mechanism of action, bioavailability and therapeutic
effects of Mn porphyrin-based redox modulators. Med Princ Pract. 2013;22(2):103–130. Epub
2012 Oct 16. PMID: 23075911; PMCID: PMC3640855.
126. Tsai HC, Li H, Van Neste L, Cai Y, Robert C, Rassool FV, Shin JJ, Harbom KM, Beaty R,
Pappou E, Harris J, Yen RW, Ahuja N, Brock MV, Stearns V, Feller-Kopman D, Yarmus LB, Lin
YC, Welm AL, Issa JP, Minn I, Matsui W, Jang YY, Sharkis SJ, Baylin SB, Zahnow CA. Transient
low doses of DNA-demethylating agents exert durable antitumor effects on hematological and
epithelial tumor cells. Cancer Cell. 2012 Mar 20;21(3):430–446. PMID: 22439938; PMCID:
PMC3312044
127. Tsao MN, Khuntia D, Mehta MP. Brain metastases: what's new with an old problem? Curr Opin
Support Palliat Care. 2012 Mar;6(1):85–90. PMID: 22123260
128. Vivanco I, Robins HI, Rohle D, Campos C, Grommes C, Nghiemphu PL, Kubek S, Oldrini B,
Chheda MG, Yannuzzi N, Tao H, Zhu S, Iwanami A, Kuga D, Dang J, Pedraza A, Brennan CW,
Heguy A, Liau LM, Lieberman F, Yung WK, Gilbert MR, Reardon DA, Drappatz J, Wen PY,
Lamborn KR, Chang SM, Prados MD, Fine HA, Horvath S, Wu N, Lassman AB, DeAngelis LM,
Yong WH, Kuhn JG, Mischel PS, Mehta MP, Cloughesy TF, Mellinghoff IK. Differential
sensitivity of glioma- versus lung cancer-specific EGFR mutations to EGFR kinase inhibitors.
Cancer Discov. 2012 May;2(5):458–471. Epub 2012 Mar 31. PMID: 22588883; PMCID:
PMC3354723
129. Voskens CJ, Sewell D, Hertzano R, DeSanto J, Rollins S, Lee M, Taylor R, Wolf J,
Suntharalingam M, Gastman B, Papadimitriou JC, Lu C, Tan M, Morales R, Cullen K, Celis E,
Mann D, Strome SE. Induction of MAGE-A3 and HPV-16 immunity by Trojan vaccines in patients
with head and neck carcinoma. Head Neck. 2012 Dec;34(12):1734–1746. Epub 2012 Jan 27.
PMID: 22287423
130. Wademan M, Ha J, Singh H, Markan Y, Sharma P, Kasamon K, Nimagada, Oh M, Citron W,
Cohen R, DeLuca R, Boutros C. Current indications, techniques, and results of cytoreductive
surgery with hyperthermic intraperitoneal chemotherapy for intra-abdominal malignancies. Surgery
Curr Res. 2012;2(4):125.
131. Waghorn BJ, Staton RJ, Rineer JM, Meeks SL, Langen KM, A comparison of the dosimetric
effects of intrafraction motion on step-and-shoot, compensator, and helical tomotherapy based
IMRT. J Appl Clin Med Phys. 2013 May 6;14(3):4210. PubMed PMID: 23652252.
132. Wang L, Feigenberg S, Fan J, Jin L, Turaka A, Chen L, Ma CM. Target repositional accuracy and
PTV margin verification using three-dimensional cone-beam computed tomography (CBCT) in
stereotactic body radiotherapy (SBRT) of lung cancers. J Appl Clin Med Phys. 2012 Mar
8;13(2):3708. PMID: 22402387
133. Wang M, Dignam JJ, Zhang QE, DeGroot JF, Mehta MP, Hunsberger S. Integrated phase II/III
clinical trials in oncology: a case study. Clin Trials. 2012 Dec;9(6):741–747. Epub 2012 Nov 22.
Review. PMID: 23180870
134. Watkins AC, Wei X, Sanchez PG, Ho H, Zhang P, Hu J, Wu ZJ, Griffith BP. Evaluation of the
infant Jarvik 2000 heart in a neonate piglet model. J Heart Lung Transpl. 2012;31(4):S259.
135. Weitner T, Kos I, Sheng H, Tovmasyan A, Reboucas JS, Fan P, Warner DS, Vujaskovic Z,
Batinic-Haberle I, Spasojevic I. Comprehensive pharmacokinetic studies and oral bioavailability of
two Mn porphyrin-based SOD mimics, MnTE-2-PyP5+ and MnTnHex-2-PyP5+. Free Radic Biol
Med. 2013 May;58:73–80. Epub 2013 Jan 15. PMID: 23328731
10
136. Wells KE, Weatherhead RA, Murigi FN, Nichol GS, Carducci MD, Selby HD, Mash EA. Organic
crystal engineering with 1,4-piperazine-2,5-diones. 8. Synthesis, crystal packing, and
thermochemistry of piperazinediones derived from 2-amino-4,7-dialkoxyindan-2-carboxylic acids.
Crystal Growth Des. 2012;12:5056–5068.
137. Williams JP, Jackson IL, Shah JR, Czarniecki CW, Maidment BW, DiCarlo AL. Animal models
and medical countermeasures development for radiation-induced lung damage: report from an
NIAID workshop. Radiat Res. 2012;177 (5):e0025–e0039. PMID: 22468702
138. Wu J, Betzing C, He TT, Fuss M, D'Souza WD. Dosimetric comparison of patient setup strategies
in stereotactic body radiation therapy for lung cancer. Med Phys. 2013 May;40(5):051709. PMID:
23635257
139. Yang X, Han-Oh S, Gui M, Niu Y, Yu CX, Yi BY. Four-dimensional dose distributions of stepand-shoot IMRT delivered with real-time tumor tracking for patients with irregular breathing:
constant dose rate vs dose rate regulation. Med Phys. 2012 Sep;39(9):5557–5566. PMID:
22957622; PMCID: PMC3436918
140. Yeo IJ, Jung JW, Patyal B, Mandapaka A, Yong Yi B, Oh Kim J. Conditions for reliable timeresolved dosimetry of electronic portal imaging devices for fixed-gantry IMRT and VMAT. Med
Phys. 2013 Jul;40(7):072102. PubMed PMID: 23822446.
141. Yeo IJ, Jung JW, Yi BY, Kim JO. Feasibility study on inverse four-dimensional dose
reconstruction using the continuous dose-image of EPID. Med Phys. 2013 May;40(5):051702.
PubMed PMID: 23635250
142. Yovino S, Maidment BW 3rd, Herman JM, Pandya N, Goloubeva O, Wolfgang C, Schulick R,
Laheru D, Hanna N, Alexander R, Regine WF. Analysis of local control in patients receiving
IMRT for resected pancreatic cancers. Int J Radiat Oncol Biol Phys. 2012 Jul 1;83(3):916–920.
Epub 2012 Jan 25. PMID: 22284684; PMCID: PMC3556989
143. Yu CX, Shao X, Zhang J, Regine W, Zheng M, Yu YS, Deng J, Duan Z. GammaPod-a new device
dedicated for stereotactic radiotherapy of breast cancer. Med Phys. 2013 May;40(5):051703. PMID:
23635251; PMCID: PMC3637326
144. Yuan Y, Cheng KS, Craciunescu OI, Stauffer PR, Maccarini PF, Arunachalam K, Vujaskovic Z,
Dewhirst MW, Das SK. Utility of treatment planning for thermochemotherapy treatment of
nonmuscle invasive bladder carcinoma. Med Phys. 2012 Mar;39(3):1170–1181. PMID: 22380348;
PMCID: PMC3292595
145. Zhang H, Diwanji T, Mistry N, Lu W, D’Souza W. TU-E-BRA-10: Personalized utility function
for radiotherapy based on pulmonary ventilation of locally advanced lung cancer patients. Med
Phys. 2012;39(6):3913.
146. Zhang HH, Gao S, Chen W, Shi L, D'Souza WD, Meyer RR. A surrogate-based metaheuristic
global search method for beam angle selection in radiation treatment planning. Phys Med Biol.
2013 Mar 21;58(6):1933–1946. PMID: 23459411; PMCID: PMC3652383
147. Zhuang J, Zhang Z, Zhang C, Xu F. 8-OH-DPAT abolishes the pulmonary C-fiber-Mediated
apneic response to fentanyl largely via acting on 5HT1A receptors in the nucleus Tractus solitarius.
Am J Physiol Regul Integr Comp Physiol. 2012;303(4):R449–458. PubMed PMID: 22696579;
PubMed Central PMCID: PMC3423994.
148. Zhang Z, Zhang C, Zhuang J, Xu F. Contribution of central μ-receptors to switching pulmonary Cfibers-mediated rapid shallow breathing into an apnea by fentanyl in anesthetized rats. Brain Res.
2012;1469:73–81. PMID: 22759907
149. Zhang Z, Zhang C, Zhou M, Xu F. Activation of opioid μ-receptors, but not δ- or κ-receptors,
switches pulmonary C-fiber-mediated rapid shallow breathing into an apnea in anesthetized rats.
Respir Physiol Neurobiol. 2012;183(3):211–217. PMID: 22796630
150. Zhang Y, Zhang X, Rabbani ZN, Jackson IL, Vujaskovic Z. Oxidative stress mediates radiation
lung injury by inducing apoptosis. Int J Radiat Oncol Biol Phys. 2012 Jun 1;83(2):740–748. Epub
2012 Jan 21. PMID: 22270165; PMCID: PMC3649017
11
151. Zhao Y, Li T, Wei X, Bianchi G, Hu J, Sanchez PG, Xu K, Zhang P, Pittenger MF, Wu ZJ, Griffith
BP. Mesenchymal stem cell transplantation improves regional cardiac remodeling following ovine
infarction,. Stem Cells Transl Med. 2012;1:685–695. PubMed PMID:23197875; PubMed Central
PMCID: PMC3659738.
152. Zhou S, Nissao E, Jackson IL, Leong W, Dancy L, Cuttitta F, Vujaskovic Z, Sunday ME.
Radiation-induced lung injury is mitigated by blockade of gastrin-releasing peptide. Am J Pathol.
2013 Apr;182(4):1248–1254. Epub 2013 Feb 8. PMID: 23395092; PMCID: PMC3620399
12